logo
logo

Eledon Pharmaceuticals (Eldn) Appoints Eliezer Katz As Chief Medical Officer

Oct 23, 2023•almost 2 years ago

Position

Chief Medical Officer

Company

Eledon

Eliezer Katz
IrvineBiotechnology

Description

Eledon Pharmaceuticals, Inc. today announced the appointment of Eliezer Katz, M.D., FACS as Chief Medical Officer with responsibility for leading the company’s clinical development programs.

Company Information

Company

Eledon

Location

19900 MACARTHUR BLVD.

Irvine, California, United States

About

Eledon Pharmaceuticals is a clinical stage biotechnology company with immunology expertise that is developing therapies to protect and prevent rejection of transplanted organs, as well as to treat amyotrophic lateral sclerosis (ALS). The Company’s lead compound in development is tegoprubart, an anti-CD40L antibody with high affinity for CD40 Ligand (also called “CD154”), a well-validated biological target with broad therapeutic potential.

Related People

Sign in to view contact details

Sign in to view contact details

Sign in to view contact details

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months